콘텐츠로 건너뛰기
주식/증권 📈 긍정적

This Medtech Beat Earnings, but the Stock Is Having Its Worst Day in 17 Years

요약

Insulet lowers its full-year revenue growth outlook, even after earnings and revenue handily beat expectations.